ArticleKidney international reports2026

Randomized Controlled Clinical Trial of Allogeneic Mesenchymal Stromal Cell Infusion in Diabetic Kidney Disease.

Norberto Perico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.